Complete dosage information for Eszopiclone — threshold, light, common, strong, and heavy dose ranges across 1 route of administration.
Full Eszopiclone profileImportant Safety Notice
Dosage information is for harm reduction purposes only. Individual sensitivity varies greatly. Always start with the lowest effective dose and work your way up slowly. Never eyeball doses — use a milligram scale.
fatal levels of respiratory depression. These substances potentiate the muscle relaxation, sedation and amnesia caused by one another and can lead to unexpected loss of consciousness at high doses. There is also an increased risk of vomiting during unconsciousness and death from the resulting suffocation. If this occurs, users should attempt to fall asleep in the recovery position or have a friend move them into it. - Dissociatives** - This combination can result in an increased risk of vomiting during unconsciousness and death from the resulting suffocation. If this occurs, users should attempt to fall asleep in the recovery position or have a friend move them into it. - United States:** On Dec 15, 2004, the United States released Eszopiclone as a treatment for insomnia. It is currently a Schedule 4 controlled substance, because it has abuse potential, just as benzodiazepines do. Possession without a prescription can lead to drug charges. - Responsible use - Depressants - Z-drugs - Benzodiazepines - Eszopiclone (Wikipedia) - Zopiclone/Eszopiclone (Erowid Vault) - Eszopiclone (Tripsit)
A common oral dose of Eszopiclone is 2–3 mg.
The threshold dose for Eszopiclone via oral is approximately 0.5 mg.
Eszopiclone typically lasts 6–8 hours via oral.